WIN Consortium to Host 2026 Symposium on Personalized Cancer Medicine in Rhode Island
The WIN Consortium is organizing a symposium on personalized cancer medicine, scheduled for October 2-3, 2026, at the Rhode Island Convention Center. This event aims to bring together experts and researchers to discuss advancements in precision oncology. A notable aspect of the symposium is the waiver of registration fees for college and precollege students who submit an abstract relevant to precision oncology research. This includes studies on tools and artificial intelligence (AI) designed to facilitate precision medicine globally. Accepted abstracts will be featured in the symposium's program, providing a platform for students to present their research, learn from professionals, network, and receive feedback. The initiative seeks to encourage participation from the next generation of scientists and foster innovation in the field of personalized cancer treatment. 
